Xcout Intel
Medivir AB
Established in 1987 and headquartered in Huddinge, Sweden, Medivir AB (publ) is a biopharmaceutical company focused on the research, development, and commercialization of pharmaceutical products. Its primary therapeutic area is oncology, with operations extending across Sweden and internationally. The company's marketed product, Zoviduo (also known as Xerclear), treats labial herpes. Medivir's robust pipeline features several investigational compounds: Remetinostat for MF cutaneous T-cell lymphoma and basal cell carcinoma; MIV-818 for liver cancer; MIV-711 for osteoarthritis; and Birinapant along with IGM-8444, both targeting solid tumors. Furthermore, Medivir engages in strategic collaborations, including a research partnership with SciLifeLab's Drug Discovery and Development Platform to discover antivirals for SARS-CoV-2, and has licensing agreements with Tango Therapeutics and Ubiquigent Limited for preclinical research programs, specifically Ubiquigent's USP7 program.
Subscribe to see Medivir AB’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Medivir AB at a glance
Medivir AB is a pharmaceuticals company headquartered in Sweden. It is publicly listed (0GP7) with a market capitalisation of $20.4M. Xcout tracks 1 named person at Medivir AB, including Jens Lindberg (Chief Executive Officer).
Medivir AB leadership
- Jens LindbergChief Executive Officer
Get Medivir AB's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Medivir AB in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- The full competitor set, tracking, exports and API access